Overview
HDR UK Cambridge is led from the Wellcome Sanger Institute, and also comprises Cambridge University, EMBL European Bioinformatics Institute, and Cambridge University Hospitals NHS Foundation Trust.
Key expertise in HDR UK Cambridge is in unifying information on genomics, other molecular traits, and electronic health records (EHRs) to gain new insights into the underlying causes and biology of diseases.
HDR UK Cambridge researchers work closely with the East of England Sub-national Secure Data Environment (SDE) and Cambridge University Hospitals Trust to make NHS data available to answer a range of health-related questions.
Regional co-leads
Regional Expertise
- Multi-modal data: Building and using longitudinal population cohorts and trials, with multi-modal data (e.g. genomic, other molecular traits and electronic health records) for aetiological research. Using genetic and molecular epidemiology to help accelerate the translation of research findings into therapies.
- Data science and AI: developing and applying tools to curate (e.g. from local and national electronic health record resources) and analyse complex data.
- Diverse population cohorts: using worldwide evidence from cohort studies in low- and middle-income countries to consider the major causes of non-communicable disease, leveraging the environmental and genetic diversity in these populations to strengthen understanding of risk factors in these countries.
- Research capacity: training cross-disciplinary researchers to address grand challenges in health data research.
